$SKIL Balance Sheet | Understand Stock

$SKIL

$5.17 -$0.10 (1.9%) Close

$SKIL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Unaudited Condensed Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2027 As of Jul 31, 2026	Q1 FY2027 As of Apr 30, 2026	Q4 FY2026 As of Jan 31, 2026	Q3 FY2026 As of Oct 31, 2025	Q2 FY2026 As of Jul 31, 2025	Q1 FY2026 As of Apr 30, 2025	Q4 FY2025 As of Jan 31, 2025	Q3 FY2025 As of Oct 31, 2024	Q2 FY2025 As of Jul 31, 2024	Q1 FY2025 As of Apr 30, 2024	Q4 FY2024 As of Jan 31, 2024	Q3 FY2024 As of Oct 31, 2023	Q2 FY2024 As of Jul 31, 2023	Q1 FY2024 As of Apr 30, 2023	Q4 FY2023 As of Jan 31, 2023	Q3 FY2023 As of Oct 31, 2022	Q2 FY2023 As of Jul 31, 2022	Q1 FY2023 As of Apr 30, 2022	Q4 FY2022 As of Jan 31, 2022	Q3 FY2022 As of Oct 31, 2021
Current assets:
Cash and cash equivalents
Restricted cash
Accounts receivable, net of allowance for credit losses of approximately $251 and $382 as of July 31, 2026 and January 31, 2026, respectively
Prepaid expenses and other current assets
Assets held for sale
Total current assets
Property and equipment, net
Goodwill
Intangible assets, net
Operating right-of-use assets
Fair value of hedge instruments
Other assets
Non-current assets associated with discontinued operations
Total assets

Current liabilities:
Current maturities of long-term debt
Borrowings under accounts receivable facility
Accounts payable
Accrued compensation
Lease liabilities
Accrued expenses and other current liabilities
Operating lease liabilities
Deferred revenue
Liabilities associated with assets held for sale
Total current liabilities
Long-term debt
Fair value of hedge instruments
Warrant liabilities
Deferred tax liabilities
Operating long-term lease liabilities
Deferred revenue - non-current
Other long-term liabilities
Long-term liabilities associated with discontinued operations
Total long-term liabilities
Commitments and contingencies

Shareholders’ equity (deficit):
Shareholders’ common stock - Class A common shares, $0.0001 par value per share: 18,750,000 shares authorized and 9,362,304 shares issued and 9,062,527 shares outstanding as of July 31, 2026, and 9,095,922 shares issued and 8,796,145 shares outstanding as of January 31, 2026
Additional paid-in capital
Accumulated (deficit)
Treasury shares
Treasury stock, at cost - 299,777 shares as of July 31, 2026 and January 31, 2026
Accumulated other comprehensive income (loss)
Total shareholders’ equity (deficit)
Total liabilities and shareholders’ equity (deficit)

Comments